Sigyn Therapeutics, Inc. (SIGY)

Sigyn Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-4.15	-3.71	-3.4	-1.6	-3.13
Depreciation & Amortization	0.01	0.01	0.02	0.01	0.08
Share-Based Compensation	0.22	0	0.25	0	0
Other Operating Activities	2.54	1.87	1.36	0.76	2.91
Operating Cash Flow	-1.38	-1.83	-1.77	-0.83	-0.14
Capital Expenditures	0	-0	-0.03	-0.01	0
Acquisitions	0	0	0	0	0.1
Investing Cash Flow	0	-0	-0.03	-0.01	0.1
Common Stock Issued	1.52	0.15	1.87	0.4	0
Other Financing Activities	-0.13	1.35	0.2	0.53	0.04
Financing Cash Flow	1.39	1.5	2.06	0.93	0.04
Net Cash Flow	0	-0.33	0.26	0.08	-0.01
Free Cash Flow	-1.38	-1.83	-1.8	-0.84	-0.14
Free Cash Flow Margin	-	-	-	-	-100.25%
Free Cash Flow Per Share	-1.26	-0.05	-0.05	-0.11	-0.27

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.